The boom in using GLP-1 drugs like Ozempic to treat obesity has resulted in a bust regarding the drugs' original purpose, which was to treat Type 2 diabetes, a new study ... use as a weight-loss ...

Study Finds Big Shift in Who's Using GLP-1 ... There has been a notable uptick in GLP-1 use since 2020, Rezaie noted. The U.S. Food and Drug Administration approved semaglutide for use as a ...

The rising use of glucagon-like peptide-1 (GLP ... of drug that mimics the glucagon-like peptide-1 hormone. It stimulates insulin secretion and reduces appetite, helping to control blood sugar and ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows. Not only is ...

"This large cohort study ... 0.83-1.25). "Because of GLP-1s' known side effect of pancreatitis, there's been some concern about links between GLP-1 use and pancreatic cancer. And this just shows ...

Eli Lilly announced Thursday the successful completion of a phase 3 trial of Orforglipron – the first small-molecule GLP-1 that is administered ... highest dose of the drug scored an A1C less ...

Weight Loss Drug Users Are Giving Up Their Vices This new study was prospective, meaning the researchers proactively tracked how people’s alcohol use changed after starting GLP-1 therapy (many ...

"The use of GLP-1 receptor ... before our study, it had not been examined on a truly national scale." Following semaglutide's approval for chronic weight management, a shift in the drug's ...